- Country: Hong Kong
- Summary: Supply of Doxazosin (Mesylate) Tablet 2mg,Betaxolol (Hcl) Eye Drops 0.25% 5ml and ETC
- HKT Ref No: 101239183
- Deadline: 31 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.:
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Procurement Plan for Supply of Doxazosin (Mesylate) Tablet 2mg,Betaxolol (Hcl) Eye Drops 0.25% 5ml,Methyldopa Tablet,Ursodeoxycholic Acid Tablet 50mg,Magnesium Sulphate Injection 50% 5ml,Methylphenidate Hcl Modified Release Cap 30mg,Budesonide Rectal Foam 2mg/Dose 14dose(S),Soluvit N (or Equiv) Infusion 10ml,Co-Amilozide Tablet,Mebeverine Hcl Prolonged Release Cap 200mg,Sirolimus Tablet 1mg,Zoledronic Acid (Aclasta) Infusion 50mcg/Ml 100ml,Rifabutin Capsule 150mg
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupply of Doxazosin (Mesylate) Tablet 2mg,Betaxolol (Hcl) Eye Drops 0.25% 5ml and ETC - Hongkong Tender
The HOSPITAL AUTHORITY, a Government sector organization in Hong Kong, has announced a new tender for Supply of Doxazosin (Mesylate) Tablet 2mg,Betaxolol (Hcl) Eye Drops 0.25% 5ml and ETC. This tender is published on HongkongTenders under HKT Ref No: 101239183 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-31.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
